RecruitingNCT06200155
Psilocybin-assisted therapy or placebo for anxiety and depression in advanced cancer
About this title
Read the official source — NCT06200155Medication studyAges 25+United States
Understand this study
Who could participate?
Listed age limits: from 25 years.
- Listed locations
- HoustonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 16, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 48
- Sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 25 Years
- Official registry ID
- NCT06200155
- Official title
Show the full official title
TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Houston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is M.D. Anderson Cancer Center.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin.
Who can participate?
Listed age limits: from 25 years.
Is this study still recruiting?
The registry lists this study as recruiting.
